ArticleArchives of medical science : AMS2013
Prevalence of ocular manifestations in systemic sclerosis patients.
Article in Archives of medical science : AMS, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 64 citations in OpenAlex.
- Utilizing Shear Wave Elastography for the Evaluation of Ocular Involvement in Systemic Sclerosis.Diagnostics (Basel, Switzerland) · 2025Article
- Bilateral Keratoconus in Diffuse Cutaneous Systemic Sclerosis: A Rare Presentation - Is There Any Role of Autoimmunity?Turkish journal of ophthalmology · 2025Article
- Ocular Manifestation in Systemic Sclerosis-A Literature Review.Life (Basel, Switzerland) · 2024Review
- Thickness of anterior sclera and corneal layers in systemic sclerosis.International ophthalmology · 2024Article
- The effect of systemic sclerosis and its subtypes on ocular anterior and posterior segment parameters.International ophthalmology · 2024Article
- Dacryoadenitis as a Rare Initial Presentation in a Patient with Suspected Crest Syndrome.European journal of case reports in internal medicine · 2024Article
- Peripheral and ocular microvascular alterations in systemic sclerosis: observations from capillaroscopic assessments, perfusion peripheral analysis, and optical coherence tomography angiography.Rheumatology international · 2024Article
- Three-Dimensional Quantitative Magnetic Resonance Imaging Cartilage Evaluation of the Hand Joints of Systemic Sclerosis Patients: A Novel Insight on Hand Osteoarthritis Pathogenesis-Preliminary Report.Journal of clinical medicine · 2023Article
- Recurrent uveitis in a patient with CREST syndrome: a case report.Annals of medicine and surgery (2012) · 2023Article
- Optical Coherence Tomography Angiography Is a Useful Tool for Distinguishing Primary Raynaud's Phenomenon from Systemic Sclerosis and/or Very Early Disease of Systemic Sclerosis.Diagnostics (Basel, Switzerland) · 2023Article
- Ocular involvement in rheumatic diseases.Reumatologia · 2023Review
- Retinal microvasculature alteration in patients with systemic sclerosis and chloroquine treatment.Quantitative imaging in medicine and surgery · 2022Article
- Role and effectiveness of complex and supervised rehabilitation on overall and hand function in systemic sclerosis patients-one-year follow-up study.Scientific reports · 2021Article
- An in vivo confocal microscopy study of corneal changes in patients with systemic sclerosis.Scientific reports · 2021Article
- Correlation of retinal and choroidal microvascular impairment in systemic sclerosis.Orphanet journal of rare diseases · 2021Article
- Ocular Manifestations in Colombian Patients with Systemic Rheumatologic Diseases.Clinical ophthalmology (Auckland, N.Z.) · 2021Article
- Prevalence of retinal changes in patients with systemic sclerosis: the association between retinal vascular changes and nailfold capillaroscopic findings.Reumatologia · 2021Article
- Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis-Case Series Report.International journal of molecular sciences · 2020Article
- Rare cause of red eye in scleroderma.BMJ case reports · 2020Article
- Dry Eye in Systemic Sclerosis Patients: Novel Methods to Monitor Disease Activity.Diagnostics (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSystemic sclerosis (scleroderma, SSc) is a severe chronic connective tissue disease caused by immune system disorders and changes in the structure and functions of blood vessels, which consequently leads to enhanced tissue fibrosis. The aim of the study was to evaluate changes in the organ of vision in systemic sclerosis patients. MATERIAL AND
methodsOverall the study involved 27 patients with systemic sclerosis. The control group comprised 27 age- and gender-matched healthy individuals. All the study subjects underwent complete ophthalmological examination that in systemic sclerosis patients additionally involved fluorescein angiography.
resultsOPHTHALMOLOGICAL EXAMINATION REVEALED HIGHER INCIDENCE OF THE FOLLOWING ABNORMALITIES IN THE STUDY GROUP, COMPARED TO THE CONTROL: symptoms of dry eye syndrome (19 eyes, p < 0.02), astigmatism(in 30 eyes, p < 0.01), posterior subcapsular cataract (10 eyes, p < 0.05), increased intraocular pressure (> 21 mm Hg were observed in 11 eyes, p < 0.002) and vascular abnormalities within fundus in fluorescein angiography (20 eyes).
conclusionsIn patients with systemic sclerosis numerous abnormalities within the vision of organ may be found. Regular ophthalmological examinations are essential among the mentioned group. The examination should be particularly focused on the presence of retinal vascular abnormalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.